Stephanie Rock

Caris Life Sciences (United States) — United States

Medicine · Health Sciences

11h-index962citations50works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiomics and Machine Learning in Medical Imaging(24), AI in cancer detection(23), Artificial Intelligence in Healthcare and Education(22), Neuroscience and Neuropharmacology Research(5), Neurotransmitter Receptor Influence on Behavior(4)

Publications50 total

Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer
Neoplasia·2026Open Access
Case Report: Advanced grade 2 meningioma with PBRM1 inactivation with prolonged response to immunotherapy
Frontiers in Oncology·2025Open Access
Supplementary Table S6 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Table S1 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Table 1 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Figure 3 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Table S5 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Data from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Figure S9 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Table S2 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Figure S4 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Figure 2 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Figure S7 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Figure 1 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Figure 4 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Figure S5 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Figure S1 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Figure S3 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Figure S6 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
Supplementary Figure S8 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
2025Open Access
page 1 of 3Next →

Frequent Co-authors

David Spetzler(24), Ari M. Vanderwalde(24), George W. Sledge(24), Hassan Ghani(23), Anthony Helmstetter(23), Jennifer R. Ribeiro(23), Todd Maney(23), Rebecca Feldman(23), Jeffrey Swensen(23), Farah Abdulla(23), Elena Florento(23), Patricia Pittman(23), Milan Radovich(23), Jaclyn F. Hechtman(23), Casey Bales(23), Myra M. George(23), David Bryant(23), Jim Abraham(23), Matthew J. Oberley(23), Harry L. June(5)